SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001126234-18-000076
Filing Date
2018-05-01
Accepted
2018-05-01 16:41:09
Documents
2
Period of Report
2018-04-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_152520725621949.html 3  
1 FORM 3 wf-form3_152520725621949.xml 3 3253
2 2018 SHERMAN POA ex-24.htm EX-24 3755
  Complete submission text file 0001126234-18-000076.txt   8367
Mailing Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010
Business Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010 515-296-5555
NEWLINK GENETICS CORP (Issuer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACCELERON PHARMA INC 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Sherman Matthew L (Reporting) CIK: 0001325710 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35342 | Film No.: 18796113